Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

Abstract Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the concomitant use of multiple drugs. DDI may occur in patients under treatment with medications used for coronavirus disease 2019 (COVID‐19; i.e., chloroquine, lopinavir/ritonavir, ribavirin, tociliz...

Full description

Bibliographic Details
Main Authors: Haleh Rezaee, Fariba Pourkarim, Samira Pourtaghi‐Anvarian, Taher Entezari‐Maleki, Touraj Asvadi‐Kermani, Masoud Nouri‐Vaskeh
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Pharmacology Research & Perspectives
Subjects:
adverse reactions
chloroquine
COVID‐19
drug‐drug interaction
Kaletra
remdesivir
Online Access:https://doi.org/10.1002/prp2.705

Internet

https://doi.org/10.1002/prp2.705

Similar Items